✦ LIBER ✦

A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis

✍ Scribed by Hiroshi Hagino; Yoshiki Nishizawa; Teruki Sone; Hirotoshi Morii; Yuji Taketani; Toshitaka Nakamura; Akira Itabashi; Hideaki Mizunuma; Yasuo Ohashi; Masataka Shiraki; Toshiomi Minamide; Toshio Matsumoto

Book ID: 116321540
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 522 KB
Volume: 44
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2009.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Head-to-head comparison of risedronate v

Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial

✍ A. D. Anastasilakis; D. G. Goulis; S. A. Polyzos; S. Gerou; G. N. Koukoulis; Z. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Effect of daily oral minodronate on vert

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

✍ T. Matsumoto; H. Hagino; M. Shiraki; M. Fukunaga; T. Nakano; K. Takaoka; H. Mori 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

Treatment With Once-Weekly Alendronate 7

Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

✍ Clifford J Rosen; Marc C Hochberg; Sydney L Bonnick; Michael McClung; Paul Mille 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB

Oral alendronate use and risk of cancer

Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study

✍ Chia-Hung Chiang; Chin-Chou Huang; Wan-Leong Chan; Po-Hsun Huang; Tzeng-Ji Chen; 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 183 KB

Effect of alendronate and vitamin D3 on

Effect of alendronate and vitamin D3 on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women

✍ Sue A Shapses; David L Kendler; Richard Robson; Karen E Hansen; Robert M Sherrel 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Menopause and increasing age are associated with a decrease in calcium absorption that can contribute to the pathogenesis of osteoporosis. We hypothesized that alendronate plus vitamin D~3~ (ALN + D) would increase fractional calcium absorption (FCA). In this randomized, double‐blind, p

A Comparison of Continuous Alendronate,

A Comparison of Continuous Alendronate, Cyclical Alendronate and Cyclical Etidronate with Calcitriol in the Treatment of Postmenopausal Vertebral Osteoporosis: A Randomized Controlled Trial

✍ O. Sahota; I. Fowler; P. J. Blackwell; N. Lawson; S. A. Cawte; P. San; T. Masud; 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 164 KB